Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg

NCT03534310 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: LIRAGLUTIDE 3 Mg/0.5 mL (18 Mg/3 mL) SUB-Q PEN INJECTOR (ML)
OTHER: lifestyle modification
OTHER: sleeve gastrectomy

Sponsor

Catholic University of the Sacred Heart